Advanced lab-grown tissues help show how special lung cells develop, shedding light on rare ACDMPV disease and suggesting potential ways to repair damage from viral infections such as COVID-19 ...

Merck revealed promising Phase 3 trial results for WINREVAIR, a new treatment aimed at pulmonary arterial hypertension (PAH). The HYPERION study involved about 320 global participants already ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

A cup and a half of leafy green vegetables could go a long way to addressing atherosclerotic vascular diseases (ASVD's), new research from Edith Cowan University (ECU), the University of Western ...

At 12 weeks, patients treated with ENV-101 showed statistically significant increases in lung volume compared with those ...

Panelists discuss how managing patients with comorbidities requires careful evaluation to distinguish true Group 1 PAH features from underlying cardiac or pulmonary disease, with a more measured ...

Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.

Among patients with pulmonary arterial hypertension, once-daily treprostinil palmitil inhalation powder for 16 weeks reduced ...